{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Sex Differences in Alzheimer\u2019s Disease: Risk Factors and Biomarkers","description":" In this first deep dive, Rachel Buckley joins host Catherine Glass to explore how Alzheimer\u2019s disease risk can be detected before symptoms appear. From blood-based biomarkers like p-tau217, to AI-driven models of cognitive resilience, the episode examines how risk, progression, and protection can be better understood and predicted over time.  Timestamps: 00:00:57:11 \u2013 Phosphorylated tau and amyloid-PET 00:08:15:05 \u2013 Biomarkers, risk, and progression 00:11:18:04 \u2013 Brain resistance and cognitive resilience 00:15:23:23 \u2013 AI biases ","author_name":"EMJ Podcast: Insights For Healthcare Professionals","author_url":"http:\/\/emghealthpodcast.libsyn.com\/website","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/41464480\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/202411765"}